KRT18 and COVID-19: We then tested the effects of IKE and NAC in vivo using keratin 18 (K18)-hACE2 mice, which express human ACE2 receptor under the K18 promoter in the epithelia, including airway epithelial cells, and recapitulate several aspects of severe and non-severe COVID-19 in humans (Dong et al., 2022).